McAdam LLC Purchases 270 Shares of Intuitive Surgical, Inc. (NASDAQ:ISRG)

McAdam LLC lifted its position in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 59.0% during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 728 shares of the medical equipment provider’s stock after purchasing an additional 270 shares during the period. McAdam LLC’s holdings in Intuitive Surgical were worth $380,000 as of its most recent filing with the Securities and Exchange Commission.

Several other institutional investors have also added to or reduced their stakes in the company. Bennett Selby Investments LP lifted its holdings in shares of Intuitive Surgical by 3.9% during the fourth quarter. Bennett Selby Investments LP now owns 449 shares of the medical equipment provider’s stock worth $234,000 after buying an additional 17 shares in the last quarter. LVW Advisors LLC raised its stake in Intuitive Surgical by 1.3% in the 4th quarter. LVW Advisors LLC now owns 1,448 shares of the medical equipment provider’s stock worth $756,000 after purchasing an additional 19 shares in the last quarter. Wesbanco Bank Inc. grew its position in shares of Intuitive Surgical by 1.6% during the 4th quarter. Wesbanco Bank Inc. now owns 1,216 shares of the medical equipment provider’s stock worth $635,000 after purchasing an additional 19 shares in the last quarter. Journey Strategic Wealth LLC increased its holdings in shares of Intuitive Surgical by 1.9% during the fourth quarter. Journey Strategic Wealth LLC now owns 1,039 shares of the medical equipment provider’s stock worth $542,000 after purchasing an additional 19 shares during the period. Finally, Hazlett Burt & Watson Inc. raised its position in shares of Intuitive Surgical by 5.8% in the third quarter. Hazlett Burt & Watson Inc. now owns 362 shares of the medical equipment provider’s stock valued at $177,000 after buying an additional 20 shares in the last quarter. 83.64% of the stock is currently owned by institutional investors.

Analysts Set New Price Targets

Several brokerages have weighed in on ISRG. Piper Sandler reaffirmed an “overweight” rating and issued a $670.00 price objective (up from $538.00) on shares of Intuitive Surgical in a report on Friday, January 24th. Barclays upped their price objective on shares of Intuitive Surgical from $610.00 to $674.00 in a research report on Monday, January 27th. Jefferies Financial Group raised their target price on shares of Intuitive Surgical from $475.00 to $575.00 in a report on Monday, January 27th. Evercore ISI upped their price target on shares of Intuitive Surgical from $490.00 to $530.00 in a report on Monday, January 27th. Finally, Raymond James lifted their price objective on shares of Intuitive Surgical from $560.00 to $688.00 and gave the company an “outperform” rating in a research note on Friday, January 24th. One analyst has rated the stock with a sell rating, five have assigned a hold rating and sixteen have assigned a buy rating to the stock. According to data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and a consensus price target of $613.10.

Insider Transactions at Intuitive Surgical

In other Intuitive Surgical news, EVP Robert Desantis sold 376 shares of Intuitive Surgical stock in a transaction that occurred on Friday, November 29th. The shares were sold at an average price of $539.00, for a total transaction of $202,664.00. Following the transaction, the executive vice president now owns 5,506 shares of the company’s stock, valued at $2,967,734. This trade represents a 6.39 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. Also, CFO Jamie Samath sold 94 shares of the company’s stock in a transaction that occurred on Wednesday, January 29th. The shares were sold at an average price of $571.11, for a total value of $53,684.34. Following the completion of the transaction, the chief financial officer now directly owns 2,630 shares of the company’s stock, valued at approximately $1,502,019.30. This represents a 3.45 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 28,843 shares of company stock valued at $15,357,560 over the last ninety days. 0.90% of the stock is currently owned by insiders.

Intuitive Surgical Price Performance

Shares of NASDAQ ISRG opened at $571.88 on Monday. Intuitive Surgical, Inc. has a 1 year low of $364.17 and a 1 year high of $616.00. The stock has a market capitalization of $203.69 billion, a P/E ratio of 89.22, a P/E/G ratio of 5.52 and a beta of 1.39. The company has a 50-day moving average price of $550.40 and a 200-day moving average price of $509.43.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.